{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-GP Ceftaroline",
        "VITEK\u00ae 2 Gram Positive Ceftaroline"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K141149",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122547"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 7, 2014",
    "Summary Letter Received Date": "May 8, 2014",
    "Submission Date": "April 8, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftaroline susceptibility",
        "Staphylococcus aureus (including methicillin-susceptible and -resistant isolates)"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Quantitative test",
        "Broth microdilution methodology"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Broth microdilution"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 AST-GP Ceftaroline antimicrobial susceptibility test for Gram positive organisms using VITEK\u00ae 2 systems",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram positive microorganisms, including Staphylococcus aureus (methicillin-susceptible and -resistant), as a laboratory aid with VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems",
    "fda_folder": "Microbiology"
}